| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $529K | -95.1% | -60.5% |
| R&D Expense | $5.8M | +5.1% | -59.5% |
| SG&A Expense | $3.0M | -8.5% | -32.9% |
| Operating Income | -$8.7M | -681.9% | +59.6% |
| Net Income | -$7.7M | -406.9% | +60.7% |
| EPS (Basic) | -$0.04 | -500.0% | +60.0% |
| EPS (Diluted) | -$0.04 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.4M | -40.1% | -29.6% |
| Accounts Receivable | $905K | -11.7% | -43.7% |
| Current Assets | $97.4M | -5.5% | -26.6% |
| Total Assets | $97.7M | -5.4% | -30.4% |
| Current Liabilities | $5.2M | +3.2% | -72.6% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$35.0M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $16.9M | — | — |
| Financing Cash Flow | $4.1M | — | — |
| Free Cash Flow | -$35.0M | — | — |
| -500.0% |
| +60.0% |
| $0 |
| — |
| — |
| Total Liabilities | $20.3M | +0.1% | -39.5% |
| Stockholders' Equity | $77.4M | -6.7% | -27.6% |